A Study to Assess the Safety, Tolerability and Effectiveness of MT-0814 for the Treatment of Age-related Macular Degeneration
Stopped The study terminated for safety reasons
Conditions
- Age-related Macular Degeneration
Interventions
- DRUG: MT-0814
- DRUG: Placebo
Sponsor
Senju Pharmaceutical Co., Ltd.
Collaborators